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Interplay between Fragile X Proteins in GluA1 regulation promotes neuronal maturation Guo et al, 2014: The Supplemental Information contains Supplemental Data [7 supplement figures (Figure S1-S7)], Extended Experimental Procedures, and References for the extended procedures. Figure S1 . Fxr2 KO mice do not display significant changes the number of newborn neurons in the adult DG, but they exhibit significant learning deficits. Related to Figure 1 
Supplemental Data:

Extended Experimental Procedures
This contains detailed experimental methods and reagents. 
References for Extended Experimental Methods
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GluA1 CDS 1-900
GluA1 CDS J. Dendrites (A) GluA1 mRNA stability analyzed in primary hippocampal neurons treated with actinomycin D. Comparisons of the different decay rates were performed by Two-Way ANOVAs. The stability of GluA1 mRNA is significantly different in KO and WT neurons (2-way ANOVA, P = 0.0245, n = 3.). Half-life of decay was calculated after transforming data to ln. (B) Gapdh mRNA stability analyzed in primary hippocampal neurons treated with actinomycin D. Comparisons of the different decay rates were performed by Two-Way ANOVAs. The stability of Gapdh mRNA is not significantly different in FXR2P-deficient (shFxr2) and control (shNC) neurons (2-way ANOVA, P = 0.83, n = 3.). Half-life of decay was calculated after transforming data to ln.
(C) Primary neurons infected with lentivirus expressing shFxr2 or control shNC were treated with a protein synthesis inhibitor, cycloheximide (CHX), during an 8-hour period. GluA1 protein levels were determined using Western blot (representative images of western blots used for data analysis in B and C). (I, J) The green and red fluorescence intensities at the indicated time point after UV conversion were normalized to the starting intensities in the hippocampal neurons transfected with the plasmids expressing DendraII-GluA1 CDS1-900 fusion protein (I, n = 6 neurons / genotype, green fluorescence, F 12,120 = 0.14, p = 0.99; red fluorescence, F 12,120 = 0.03, p = 1) or DenraII-GluA1901-1800 fusion protein (J, n = 6 neurons / genotype, green fluorescence, Representative images (left) and sample traces generated by Neurolucida™ (right) of RFP-expressing newborn neurons at 4 weeks post-retrovirus injection. (Scale bars = 50 µm)
Extended Experimental Procedures Mice All animal procedures were performed according to protocols approved by the University of Wisconsin-Madison Care and Use Committee. The Fxr2 KO mouse strain on the C57B/L6 genetic background was as described previously (Bontekoe et al., 2002; Guo et al., 2011b) . The Fmr1 KO mice bred on the C57B/L6 genetic background was as described previously (1994; Luo et al., 2010) .
In vivo Neurogenesis Analysis and Immunohistology
In vivo neurogenesis analyses were performed essentially as we've previously described Smrt et al., 2007) . Mice were given 4 injections of BrdU (50mg/kg) within 12 hours to label all dividing cells in adult germinal zones within this time period and sacrificed at 4 hours post-last injection based on published paradigm (Guo et al., 2011b) . Mice were then euthanized at 4 weeks after the last BrdU injection. The primary antibodies used were: rat-anti-BrdU (1:3000, Abcam, ab-6326), mouse anti-NeuN (1:5000; Chemicon International, Temecula, CA), Fluorescent secondary antibodies were used at 1:250 dilutions (donkey from Jackson ImmunoResearch or goat from Invitrogen). Total number of BrdU+ cells in the DG and olfactory bulb were quantified and phenotype analysis of BrdU + cells was performed as described previously (Guo et al 2011, neuron) .
For immunohistochemical analysis of brain sections, floating brain sections were blocked in the TBS buffer containing 3% normal serum and 0.25% triton-X 100, then the primary antibodies used were chicken anti-GFP (Invitrogen, Carlsbad, CA, #A10262), mouse neuronal nuclear antigen (NeuN; Chemicon, MAB377 Chemicon), rabbit anti-activated Caspase 3 (Cell Signaling Technology, Beverly, MA), goat anti-Doublecortin (Santa Cruz), rabbit anti-Doublecortin (Cell Signaling Technology, Beverly, MA), mouse anti-FXR2P, rabbit anti-GluA1, and mouse anti-GluA1. Fluorescent secondary antibodies were used at 1:500 dilutions (donkey from Jackson ImmunoResearch or goat from Invitrogen).
DNA Plasmids
DNA fragments corresponding to coding sequence (CDS) and 3' untranslated region (3'UTR) of GluA1 mRNA were cloned by PCR using a mouse full-length GluA1 cDNA (NM_008031; Lynn Regan, Yale University, New Haven, CT) as the template and the primers listed below. The PCR fragments were directly cloned into the pCRII vector (Invitrogen) and then pSicheck2 dual luciferase vector (Invitrogen) at the NotI and XhoI restriction sites. For cloning into Dendra-2 C1 vector (Evogen), GluR1 fragments were amplified by using another set of primers (listed below) and cloned into the EcoRI and XhoI sties.
Retroviral vector expressing shFxr2 and eGFP was described previously (Guo et al., 2011b) . Retroviral vector expressing shFmr1 and eGFP was cloned from our published lentivector expressing shFmr1 and GFP . The U1-shRNAs cassettes (Suresilencing shRNA vector, Qiagen) were cloned between the HpaI and ClaI sites of a modified CAG-EGFP vector (Zhao et al. 2006; Smrt et al. 2007) .
Retroviral vector expressing Phlourin-GFP was created by cloning the pHlourin-GluA1 cassette from pRK5.pHluorin-GluA1 plasmid (Makino and Malinow, 2009 ) (a gift from Dr. Richard L. Huganir, Johns Hopkins University) into HindIII and BamH1 sites of CAG-GFP retroviral vector . Retroviral vector expressing GluA1 and GFP linked by a 'self-cleaving' peptide, T2A, was created by using PCR of GluA1 coding sequence followed by cloning into HindIII and NotI sites of the retroviral vector .
The shRNA-insensitive GluA1 (mtGluA1) and FXR2P (mtFXR2P) were created by cloning of their mutant coding sequences (CDSs) into a pCDNA3 vector. The mutant CDS of GluA1 was created by replacing shGluA1 targeting site 5'-AGCGACAGCTTTGAGATGACTTA-3' with 5'-AGTGATAGTTTCGAAATGACATA-3' without changing amino acid sequence. Similarly, the mutant CDS of FXR2P was created by replacing shFxr2 targeting site 5'-ATGGTTCCCTTCATATTTGTT-3' with 5'-ATGGTACCGTTTATCTTC GTC -3'. Therefore, the mutated CDS of GluA1 (mtGluA1) and FXR2P (mtFXR2P) have change in amino acid sequences.
Primers for GluA1 fragments cloned into pCRII and psiCheck2: GluA1 ) , and Dr. Gage (The Salk Institute) and was described in their publication (Vivar et al., 2012) . The construct expresses nucleus-localized green fluorescent protein (GFP), the avian viral receptor TVA and the rabies virus glycoprotein (Rgp) under the control of a synapsin promoter, each gene was linked by a 'self-cleaving' peptide, 2A.
RNA Immunoprecipitation
RNA-IP was performed as described (Guo et al., 2011b; Luo et al., 2010) . Briefly, WT and Fxr2 KO hippocampi were harvested and homogenized in 1ml of ice-cold lysis buffer (10 mM Hepes [pH 7.4], 200 mM NaCl, 30 mM EDTA, and 0.5% Triton X-100) with 2X complete protease inhibitors (Boehringer-Mannheim). Nuclei and debris were pelleted at 3,000 X g for 10 min; the supernatant was collected and raised to 300 mM NaCl, and clarified at 14,000 X g for 30 min. The resulting supernatant was pre-cleared for 1 h with 100 µl recombinant protein G agarose (Invitrogen) (washed with lysis buffer first). An aliquot of pre-cleared input was saved for RNA extraction (200 µl) and protein analysis (100 µl). A monoclonal antibody against FXR2P (F1554, Sigma) was incubated with recombinant protein A dynabeads at 4ºC for 2 h and washed 3 times with lysis buffer. RNase Inhibitors (Roche) will be added to the remaining lysates. The pre-cleared lysates were immunoprecipitated with antibody-coated recombinant protein G agarose at 4ºC for 2 hours. After third wash with the lyses buffer, 10% of immunoprecipitate was saved for protein analysis. The remaining was washed one more time and the immunoprecipitate was re-suspended into Trizol (Invitrogen) for RNA isolation.
RT-PCR, Real-Time PCR, and Pathway Arrays
RT-PCR and real-time PCR were performed using standard methods as described (Guo et al., 2011b; Liu et al., 2010) . The first-strand cDNA was generated by reverse transcription with oligo (dT) primer or random hexamers. Standard RT-PCR was performed using GoTaq DNA polymerase (Promega). To quantify the mRNA levels using real-time PCR, aliquots of first-stranded cDNA were amplified with gene-specific primers and Power SYBR Green PCR Master Mix (Applied Biosystems) using a
Step-1 Real-Time PCR System (Applied Biosystems). The PCR reactions contained 20-40 ng of cDNA (except the cDNA for the IP, for which 5% of the cDNA was used for each gene examined), Universal Master Mix (Applied Biosystems), and 300 nM of forward and reverse primers in a final reaction volume of 20 µl. The ratio of different samples was calculated by the data analysis software built in with the Step-1 Real-Time PCR System. For RIP-real time PCR, cDNA from IP and input was used and then normalized IP sample to Input sample. The relative enrichment of RNA in WT compared with Fxr2 KO samples were then calculated with Fxr2 KO samples set as "1".
To determine differential gene expression between WT and Fxr2 KO, cDNA were synthesized from the RNA of WT and Fxr2 hippocampi as described above. 40 ng cDNA was added into each well of a 96-well pre-manufactured mouse Glutamate and GABA Pathway Arrays (Qiagen/SABioscience). Each sample was applied to one array and independent duplicates were analyzed for WT and Fxr2 KO. Real time PCR and data analyses were performed according to manufacturer's instruction (Qiagen/SABioscience). Briefly, the expression level of each gene was obtained by comparing to internal controls on the same array. The relative expression levels of genes in Fxr2 KO compared with WT samples were then calculated with WT samples set as "1". The sequences of primers used for RIP-PCR reactions are as the following: Hippocampal neurons were isolated and transfected as described previously . Hippocampal neurons from wild type E17.5 fetal mice or P0 neonate mice were grown as dispersed mixed cell cultures. Hippocampal neurons were transfected on day 4 (DIV 4) as they were undergoing dendritic and axonal morphogenesis during this time. Transfection was performed as described using Lipofectamine 2000 (Life Technologies) or Calcium phosphate method (Xia et al., 1996) At 48-hours after transfection; the neurons were fixed and stained as described below.
Transfection efficiencies were 1-2%. Neuronal dendritic complex were analyzed using Neurolucida (MicroBrightField) or IMARIS (Olympus).
Cycloheximide treatment
Cycloheximide (Sigma) treatment was carried out as described . Briefly, at 9 DIV, cycloheximide was added to culture medium at 50 µg/ml. Cells were collected at different time points (from 1 hour to 8 hours). The cells were then lysed and 30 µg of proteins were loaded to each lane for Western blotting analysis using an antibody against GluA1 (see below).
Actinomycin D Treatment and mRNA Stability Assay
Culture hippocampus neurons were treated with 10 mg/ml of actinomycin D (Sigma-Aldrich) to inhibit gene transcription as described (Guo et al., 2011b; Luo et al., 2010) and neurons were collected at various time intervals for RNA isolation and real time PCR analysis. GluA1 mRNA levels were normalized to Gapdh. RNA decay kinetics and half-life were analyzed using published method: (Beckel-Mitchener et al., 2002; Bolognani et al., 2006; Perrone-Bizzozero et al., 1993) . Briefly, we used exponential function M = M 0 e -ƛt (M: amount of mRNA at t time, M0: amount of mRNA t t=). ƛ= (ln)/T 1/2 (T 1/2 is the half-life of the mRNA).
In Vitro Transcription of Biotin-Labeled GluR1 mRNA and Binding Assay
This procedure was carried as previously published (Guo et al., 2011b) . Briefly, the pCRII-TOPO vector containing GluA1 fragments as described above was linearized using HindIII or SpeI restriction enzymes to create anti-sense or sense templates for in vitro transcription. To generate biotin-labeled GluA1 mRNA fragment, linearized vectors were in vitro transcribed using AmpliScritbeTM T7-FlashTM biotin-RNA transcription Kit (ASB71110, Epicentre Biotechnologies).
To determine whether synthetic biotinylated GluA1 mRNA fragments could bind endogenous FXR2P, protein lysate was prepared by homogenizing mouse hippocampi using RIPA buffer (50mM Tris HCl pH 8, 150 mM NaCl, 1% NP-40, 0.5% sodium Deoxycholate, 0.1% SDS). Then, thirty micrograms of purified biotinylated GluA1 transcripts were incubated with 500 µg of total protein in the binding buffer (10 mM HEPES, pH 7.4, 3 mM MgCl2, 5% glycerol, and 1 mM DTT) for 30 min at room temperature to allow the binding of biotinylated RNA and their binding proteins. Yeast transfer RNA (50 ng/ml) and heparin (5 mg/ml) were then added to the mixture to block non-specific binding and the binding reaction was allowed to continue for 10 more min. Dynabeads M-280 streptavidin (112-05D, Invitrogen) was then added to the mixture, and incubated with constant mixing overnight at 4°C. To collect the protein bound by biotinylated GluA1 mRNA fragments, the beads were washed three times with 1x binding buffer and resuspended in 1x binding buffer with SDS gel loading dye to dissolve protein bound to biotinylated GluA1 RNA fragments. The proteins in the pull-down material were separated by 4-20% SDS-PAGE gel, transferred to nitrocellulose membrane for Western blot analysis using an anti-FXR2P antibody or anti-FMRP antibody.
Subcellular Fraction Isolation
Isolation of cell surface protein ( Figure 5A -C, and Figure S6 ) was performed using published method. (Soden and Chen, 2010) To isolate the cell surface fraction from in vitro culture neurons and brain tissue, Brain tissue and 7-9 DIV cultured cortical neurons were washed with cold PBS/Mg 2+ Ca 2+ , and surface proteins were biotinylated with 1 mg/ml Ez-link sulfo-NHS-SS-biotin (Thermo) in PBS/Mg 2+ Ca 2+ for 25 min on ice. Cells were washed with 0.1 M glycine in ice-cold PBS/Mg 2+ Ca 2+ to stop additional biotinylation of the surface proteins. After additional washes with ice-cold PBS, brain tissue and cells were collected and solubilized in RIPA buffer. Lysates were centrifuged to remove cell debris and nuclei at 14,000 rpm for 20 min, and supernatants were rotated with Dynabeads M-280 streptavidin (Invitrogen) for 2 h at 4°C to bind biotinylated proteins. Beads were then pelleted and washed four times with RIPA buffer. Biotinylated surface proteins were eluted from beads and cell surface GluA1 expression levels were assessed by Western blot analysis using an anti-GluA1 antibody (see below)
Western Blotting Analyses Protein samples were separated on SDS-PAGE gels (Bio-Rad) and then transferred to PVDF membranes (Millipore). Membranes were processed following the Li-CoR Western blotting system (Li-CoR). FXR2P (1:1000. Sigma), FMRP (1:1000, Millipore), GluA1 (1:500, Millipore), GABAɣ2
(1:1000, Abcam) and GABAB1 (1:1000, Abcam) were used as primary antibodies. Fluorescence-labeled secondary antibodies were obtained from Li-CoR. For loading controls, membranes were stripped and reprobed with the mouse antibody against β-Actin (Sigma A5441). Quantification was performed by using software ImagJ. At least n=3 independent blots were used for statistical analysis.
Luciferase reporter assay
Cells were transfected with psicheck-2 containing GluA1 DNA fragment using phosphorylated-calcium method. After 48 hours transfection, HEK293 cells were washed with PBS two times and lysed with 1X passive lysis buffer (200 µl) from the dual-luciferase reporter assay system. According to the manufactory's protocol, 20 µl lysate supernatant were used for the assay. GluA1 translation was determined by Renilla luciferase activities normalized to control firefly luciferase.
Photo-convertible Live Cell Imaging and Data Analysis
Mouse hippocampal neurons (DIV 4) were transfected with DNA plasmids expressing Dendra-GluR1 fragment fusion proteins using Lipofectamine TM 2000. At 4-6 days post-transfection, neurons were placed in a temperature controlled chamber stage (Brook Industries) with constant 5% CO2 supply and maintained at 37°C. Imaging was accomplished using Nikon A1 laser scanning confocal with 20 X air objective lens. Potoconversion were accomplished by using laser through a DAPI filter for 30 sec. After the photoconversion, images were acquired at 15 min intervals for 1 h. The mean green and red fluorescence intensity (pixel intensity) was obtained using NIS-Elements C software. The rate of new protein synthesis was calculated by the fold increase of the mean green fluorescence obtained after at different time points after photo-conversion compared to that obtained immediately after photoconversion. The protein degradation rate of newly synthesized protein was calculated from the fold decreased of the mean red fluorescence obtained at different time points after photoconversion compared to that obtained immediately after photo-conversion.
In vivo Virus Grafting
In vivo virus grating was performed as described (Guo et al., 2011b; Liu et al., 2010; Smrt et al., 2010) . Briefly, 7-to 8-week-old C57B/L6 male mice were anesthetized with isofluorane, and virus (1 µl with titer greater than 5X10 8 /ml for retrovirus, and 4 X 10 6 /ml for rabies virus) was injected stereotaxically into the dentate gyrus (DG) using the following coordinates relative to bregma, caudal: −2.0 mm; lateral: +/−1.7 mm; ventral: −1.9 mm. For SVZ targeting, coordination was used relative bregma, rostral: 0.7 mm; lateral, +/−1.2 mm; ventral, −1.6 mm. At 2 or 4 weeks viral grafting, mice were perfused for neuronal maturation analysis. Mice were deeply anesthetized with pentobarbital and perfused with saline followed by 4% PFA. For dual retroviruses injection, Retro-pHluorinGluA1 and Retro-shRNA were mixed by 1:1 ratio. 1 µl mix retroviruses was injected stereotaxically into the dorsal ganglia (DG) using the following coordinates relative to bregma, caudal: −2.0 mm; lateral: +/−1.7 mm; ventral: −1.9 mm For rabies viral retrograde targeting experiment, Rabies virus EnvA-ΔG-MCh (1 µl) was delivered using the following coordinates relative to bregma, caudal: −2.0 mm; lateral: +/−1.7 mm; ventral: −1.9 mm. The retrovirus-treated mice were injected with rabies virus EnvA-ΔG-MCh 30days later.
3D Tracing of Retroviral Labeled New Neurons
3D analyses of retroviral labeled new neurons were performed as described . For dendritic branching analysis on 300-µm-thick floating brain sections containing hippocampus or 200-µm-thick brain sections containing olfactory bulb, eGFP+ or RFP+ neurons were imaged on a Nikon A1 confocal or a Zeiss Aptome microscope with a 20 X objective. Z-stacks of eGFP+ or RFP+ dendrites were captured at 3 µm intervals and the dendrites and the cell body of single eGFP+ or RFP+ neurons were analyzed by Neurolucida software with 3D module plug-in (MicroBrightField, Inc. Williston, VI, http://www.mbfbioscience.com/). Roughly 20-30 neurons per DG were traced. Data were extracted for Sholl analysis and total dendritic length for each eGFP+ or RFP+ neuron.
Quantification of presynaptic integration using rabies virus-based retrograde tracing method
The number of double-labelled hGFP + mCh + and mCh + only cells, was quantified in 1:6 series (240 µm apart) of coronal sections (40 µm) through the dorsal-ventral extent of the brain. The ratio of mCh + over hGFP + mCh + was used to determine the presynaptic contact of newborn neurons in the DG.
In vivo Cell Surface GluA1 Analysis
The floating brain sections were blocked in blocking solution (10% donor goat serum in TBS) for 1 h at room temperature. The brain sections were then incubated in chicken monoclonal anti-GFP antibody (Invitrogen, 1:1000 dilutions in blocking solution) in overnight at 4°C, followed by three 5 min washes with TBS at room temperature. The sections were then incubated in anti-mouse Alexa 647-conjugated secondary antibodies (Invitrogen). The mean red and far-red fluorescence intensity (pixel intensity) was obtained using NIS-Elements C software. The surface GluA1 expression was determined by mean far-red fluorescence over red fluorescence.
GluA1 Synaptic Current Analysis
GluA1ct-GFP construct, made as previously described (Hu et al., 2008; Kielland et al., 2009; Qin et al., 2005) , was expressed in hippocampal DG neurons in intact brains of postnatal 17-21 days old mice using Sindbis virus. Briefly, animals were initially anesthetized by an intraperitoneal injection of ketamine and xylazine (10 and 2 mg/kg, respectively). Animals were then placed in a stereotaxic frame and one 1×1 mm hole was opened above the right side of the somatosensory cortex. A glass pipette was used to make pressure injections of ~100 nl of low-titer viral solution in the hippocampal DG region according to stereotaxic coordinates. About 16 h after injections, acute hippocampal slices were prepared from these animals for in vitro electrophysiology experiments. Simultaneous whole-cell recordings were obtained from nearby infected and control non-infected hippocampal DG neuron pairs (Hu et al., 2008; Qin et al., 2005) , under visual guidance using fluorescence and transmitted light illumination with two Axopatch-200B amplifiers (Axon Instruments, Foster City, CA). The normal bath solution (33±1.5°C), containing (in mM): NaCl 125, KCl 2.5, CaCl 2 2, MgCl 2 1, NaHCO 3 25, NaH 2 PO 4 1.25, glucose 11, and picrotoxin 0.1 at pH 7.4, was used. The bath solutions were gassed with 5% CO 2 /95% O 2 . Patch recording pipettes (3-6 MΩ) contained (in mM): cesium methanesulfonate 115, CsCl 20, HEPES 10, MgCl 2 2.5, Na 2 ATP 4, Na 3 GTP 0.4, sodium phosphocreatine 10, EGTA 0.6, and spermine 0.1, at pH 7.25. Synaptic responses were evoked by bipolar electrodes with single voltage pulses (200 µs, up to 20 V) placed in the hippocampal the perforant pathway about 300 µm away from the recorded hippocampal DG cells. Synaptic AMPA responses at -60 mV and +40 mV were averaged over 90 trials. To minimize the effect from AMPA responses, the peak NMDA responses at +40 mV were measured after digital subtraction of estimated AMPA responses at +40 mV. Sixteen to eighteen neurons from at least 3 mice in each condition were used for data analysis.
In Uterus Electroporation (IUE)
IUE was performed based on published method . The plasmids were prepared using QIAGEN Endofree plasmid maxi kit (QIAGEN). For IUE, pregnant female mice at 14.5 day gestation were anesthetized with isoflurane. The uterine horns were exposed, and 1 µl plasmid DNA (5 µg/µl) was microinjected through the uterus into the lateral ventricles of embryos by pulled glass capillaries (Drummond Scientific Co., Broomall, PA). Electroporation was accomplished by holding the injected brain through the uterus with forcep-type electrodes CY650-P5 (Protech International, Inc., San Antonio, TX) and delivering square electric pulses (five pulses; duration, 50 msec each; interval, 950 msec) to the embryos using electroporator CUY-21 (Protech International). The mice were allowed to be born and brains were harvested and analyzed at postnatal d17.
Trace Conditioning Tests
These tests were performed as described (Guo et al., 2011a; Guo et al., 2012) . Apparatus: Animals were placed into a Coulbourn Habitest™ fear conditioning system equipped with a stainless-steel grid floor for administration of a foot shock. Method for training and testing trace fear conditioning was as described by (Paz et al., 2007) .
Training: After 90-s of habituation in the conditioning apparatus, a 15-s tone of 80 dB was presented. After a 30-s delay a 1s electric foot shock of 0.7mA was presented. This cycle was presented a total of 7 times with a 210-s inter-trial interval. Mice were then returned to their home cages.
Testing: At 24 hours following training mice are tested for both tone and context freezing. For the tone freezing test, mice were placed into a clean rat sized housing cage. After 3 min of acclimation, mice were exposed to a series of three 15-s tones of 80 dB, without subsequent shock, separated by a 165-s ITI. Freezing behavior during tone including the first 90 s immediately following the tone was measured. For the context freezing, mice were placed into the conditioning context for 180 s and were observed for freezing behavior throughout the context testing period. Movement, other than that associated with respiration, was recorded. Behavior was analyzed in a blind fashion with regard to genotype and drug treatment. All training was videotaped for subsequent viewing, re-scoring and documentation. The trace conditioning apparatus was cleaned between each mouse with 70% isopropylalcohol.
Delayed Nonmatch to Place-8-Way Radial Arm Maze (DNMP-RAM) Test
This test was performed based on published method (Clelland et al., 2009; Guo et al., 2011a; Guo et al., 2012) . Mice were maintained on a caloric restricted diet (1.5 gms of food per day) beginning 2 days prior to testing continuing throughout the testing period. Testing was conducted over 5 consecutive days with 2 sessions on each of the arm separations in the morning and two sessions in the afternoon. On the first two days of testing mice were permitted to self-correct or if they failed to self-correct in 90 seconds, were placed in the baited arm for 60 seconds prior to being returned to the home cage.
In a delayed non-match to position or place paradigm, mice were presented with a choice between a familiar and a novel arm where the correct choice is the novel arm. Mice received 8 trials/day for 5 consecutive days (20 trials of each spatial separation). Mice received one trial (consisting of a sample phase + choice phase) and were returned to a holding cage, and all other mice were tested before the second round of testing began.
In the sample phase, only the start and sample arms were accessible to the mouse and the sample arm was bated with mouse chow and honey nut cheerios™. Mice were removed from the maze and placed in a holding cage if they had either spent 30s in the sample arm or had left the sample arm. During the choice phase, a new arm is open and baited with food while the start and sample arms are open but not baited. The correct choice arms varied in distance from the sample arm by either 2 (separation 2) or 4 arms (separation 4). Mice that entered the correct choice (food baited) arm were considered to have scored as correct, while entry into the sample arm or start arm were scored as incorrect. Failure to make a selection in 3 minutes was also scored as incorrect, although this happened rarely. Mice were allowed to self correct choices and retrieve the cheerio before being removed from the maze. Each day mice received 2 trials (sample + choice phase) for each of the two separations (separation 2 and separation 4) per day for 5 consecutive days.
The radial arm maze was rotated between sample and choice presentations such that the exact spatial location within the room for the start and sample arms were held constant during the trials but the arms themselves changed to prevent odor cues from being utilized. The rotation took approximately 15 seconds. Repeated measures ANOVA between group and separations were carried out using SPSS (v.18) for each experiment Post hoc Student's t-tests with Bonferroni corrections were used as needed.
Statistical Analysis
Statistical analysis was performed using ANOVA and Student's t test, unless specified, with the aid of SPSS version 22 and Graphpad software. Two tailed and unpaired t-test was used to compare two conditions. One-Way ANOVA was used for comparison among multiple experimental conditions. Bonderroni post hoc test was used when compare among each condition. Whereas Dunnett post hoc test was used when compare multiple conditions to the same control. Scholl analysis was carried out using a multivariate analysis of variance (MANOVA) using SPSS statistical software. All data were shown as mean with standard error of mean (mean ± SEM). Probabilities of p < 0.05 were considered as significant.
